Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2010 | Nomograms for risk of heptocellular carcinoma in patients with chronic heaptitis B virus infection | Yang, HI; Sherman, M; Su, J; Chen, PJ; Liaw, YF; Iloeje, UH; Chen, CJ | J Clin Oncol 28:2437-2444 | | | |
2019 | Taiwan consensus statement on the management of chronic hepatitis B. | Chien, RN; Kao, JH; Peng, CY; Chen, CH; Liu, CJ; Huang, YH; Hu, TH; Yang, HI ; Lu, SN; Ni, YH; Chuang, WL; Lee, CM; Wu, JC; Chen, PJ; Liaw, YF | JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 118(1 Pt 1), 7-38 | | | |
2019 | Taiwan's health-care system and administration are independent of China | Tsai, DH; Lee, MH; Chen, DS; Liaw, YF; Yang, PC; Huang, YH; Chen, CJ | Lancet (London, England) 394(10208), 1516 | | | |
2008 | Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma | Chou, YC; Yu, MW; Wu, CF; Yang, SY; Lin, CL; Liu, CJ; Shih, WL; Chen, PJ; Liaw, YF; Chen, CJ | Gut 57, 91-97 | | | |
1993 | Vitamin A, Vitamin E or beta-carotene status and hepatitis B-related hepatocellular carcinoma. | Pan, WH; Wang, CY; Huang, SM; Yeh, SY; Lin, WG; Lin, DI; Liaw, YF | Annals of epidemiology 3(3), 217-224 | | | |